NRD
CRL icon

Nebula Research & Development’s Charles River Laboratories CRL Stock Holding History

Nebula Research & Development’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,130
Closed -$778K – 213
2025
Q2 		$778K Buy
+5,130
New +$684K 0.07% 495

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Nebula Research & Development's CRL Position: Q3 2025 in Review

Nebula Research & Development sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 5,130 shares — an estimated $778K sold.

Nebula Research & Development first reported a position in CRL in Q2 2025 and held it in 1 quarter. The position peaked at $778K in Q2 2025. 555 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Nebula Research & Development reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 5,130 Charles River Laboratories shares in Q3 2025, an estimated $778K.
  • Nebula Research & Development first reported a position in Charles River Laboratories in Q2 2025 and held it in 1 quarter.
  • Nebula Research & Development's Charles River Laboratories position peaked at $778K in Q2 2025.
  • 555 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.